Literature DB >> 26613847

The paroxetine controversy: lessons for ketamine trials.

Melvyn W Zhang1, Roger C Ho2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26613847     DOI： 10.1016/S2215-0366(15)00472-1

Source DB:  PubMed          Journal:  Lancet Psychiatry        ISSN： 2215-0366            Impact factor:   27.083


× No keyword cloud information.
  1 in total

1.  Analysis of print news media framing of ketamine treatment in the United States and Canada from 2000 to 2015.

Authors:  Melvyn W B Zhang; Ying X Hong; Syeda F Husain; Keith M Harris; Roger C M Ho
Journal:  PLoS One       Date:  2017-03-03       Impact factor: 3.240
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.